Amphastar director David Maris resigns effective immediately; no disagreement with company

Amphastar Pharmaceuticals, Inc.

David Maris resigned from the Board on August 19, 2021, effective immediately.
Resignation is not the result of any disagreement with company operations, policies, or practices.
Company expressed appreciation for Maris's service and contributions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Maris

Director

AMPH · Amphastar Pharmaceuticals, Inc.

Effective: 2021-08-19
Filed: August 23, 2021, 7:59 PM ET

On August 19, 2021, David Maris tendered his resignation to the Board of Directors (the “ Board ”) of Amphastar Pharmaceuticals, Inc. (the “ Company ”) effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Maris resigned as Director at Amphastar Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 19, 2021, David Maris tendered his resignation to the Board of Directors (the “ Board ”) of Amphastar Pharmaceuticals, Inc. (the “ Company ”) effective immediately.

View on SEC.gov

Amphastar Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001297184-21-000057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.